FDA Approves Biopharma Company’s Anthrax Vaccine
July 21, 2023
Reuters (7/20, Roy) reports that the FDA approved Emergent BioSolutions’ “anthrax vaccine for use in adults aged 18 through 65.” The newly approved “vaccine, Cyfendus, has been approved for use following suspected or confirmed exposure to a type of bacter...